2024-04-01 2025-03-31 false Capium Accounts Production 1.1 07578352 2024-04-01 2025-03-31 07578352 bus:AbridgedAccounts 2024-04-01 2025-03-31 07578352 bus:FRS102 2024-04-01 2025-03-31 07578352 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 07578352 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 07578352 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 07578352 2024-04-01 2025-03-31 07578352 2025-03-31 07578352 bus:RegisteredOffice 2024-04-01 2025-03-31 07578352 core:WithinOneYear 2025-03-31 07578352 core:AfterOneYear 2025-03-31 07578352 1 2024-04-01 2025-03-31 07578352 bus:Director1 2024-04-01 2025-03-31 07578352 bus:Director1 2025-03-31 07578352 bus:Director1 2023-04-01 2024-03-31 07578352 2023-04-01 07578352 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 07578352 2023-04-01 2024-03-31 07578352 2024-03-31 07578352 core:WithinOneYear 2024-03-31 07578352 core:AfterOneYear 2024-03-31 07578352 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 07578352 core:PlantMachinery 2024-04-01 2025-03-31 07578352 core:PlantMachinery 2025-03-31 07578352 core:PlantMachinery 2024-03-31 07578352 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 07578352 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 07578352 core:NetGoodwill 2024-04-01 2025-03-31 07578352 core:NetGoodwill 2025-03-31 07578352 core:NetGoodwill 2024-03-31 07578352 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 07578352 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 07578352 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 07578352 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 07578352 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 07578352 core:Non-currentFinancialInstruments 2025-03-31 07578352 core:Non-currentFinancialInstruments 2024-03-31 07578352 core:ShareCapital 2025-03-31 07578352 core:ShareCapital 2024-03-31 07578352 core:RetainedEarningsAccumulatedLosses 2025-03-31 07578352 core:RetainedEarningsAccumulatedLosses 2024-03-31 07578352 dpl:Item1 2024-04-01 07578352 dpl:Item1 2025-03-31 07578352 dpl:Item1 2023-04-01 07578352 dpl:Item1 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 07578352
England and Wales

 

 

 

S K PHARMACARE LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 April 2024

End date: 31 March 2025
 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Intangible fixed assets 3 580,500    645,000 
Tangible fixed assets 4 198,000    264,000 
Investments 5 400,000   
1,178,500    909,000 
Current assets      
Stocks 67,498    59,548 
Debtors: amounts falling due within one year 83,665    6,161 
Debtors: amounts falling due after one year 47,450    47,450 
Cash at bank and in hand 54,415    80,502 
253,028    193,661 
Creditors: amount falling due within one year (693,557)   (319,990)
Net current assets (440,529)   (126,329)
 
Total assets less current liabilities 737,971    782,671 
Creditors: amount falling due after more than one year (207,900)   (222,900)
Provisions for liabilities (50,074)   (66,000)
Net assets 479,997    493,771 
 

Capital and reserves
     
Called up share capital 1    1 
Profit and loss account 479,996    493,770 
Shareholders' funds 479,997    493,771 
 


For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 31 December 2025 and were signed by:


-------------------------------
Sunil Kumar
Director
1
General Information
S K Pharmacare Limited is a private company, limited by shares, registered in England and Wales, registration number 07578352, registration address 141 Beaconsfield Street, Newcastle Upon Tyne, NE4 5JP.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Group accounts
The company is a parent company within the meaning of the Companies Act 2006. The company is entitled to, and has taken advantage of, the exemption from preparing group accounts provided by Section 399 of the Companies Act 2006, as the company and its subsidiaries together qualify as a small group in accordance with Section 383 of the Act.

Accordingly, these financial statements present information about the company as an individual entity only and do not contain consolidated financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Goodwill
Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of years.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 5 Straight Line
Fixed asset investments
Fixed asset investments are stated at cost less provision for any permanent diminution in value.
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

Average number of employees during the year was 12 (2024 : 8).
3.

Intangible fixed assets

Cost Goodwill   Total
  £   £
At 01 April 2024 645,000    645,000 
Additions  
Disposals  
At 31 March 2025 645,000    645,000 
Amortisation
At 01 April 2024  
Charge for year 64,500    64,500 
On disposals  
At 31 March 2025 64,500    64,500 
Net book values
At 31 March 2025 580,500    580,500 
At 31 March 2024 645,000    645,000 


4.

Tangible fixed assets

Cost or valuation Plant and Machinery   Total
  £   £
At 01 April 2024 330,000    330,000 
Additions  
Disposals  
At 31 March 2025 330,000    330,000 
Depreciation
At 01 April 2024 66,000    66,000 
Charge for year 66,000    66,000 
On disposals  
At 31 March 2025 132,000    132,000 
Net book values
Closing balance as at 31 March 2025 198,000    198,000 
Opening balance as at 01 April 2024 264,000    264,000 


5.

Investments

Cost Other investments other than loans   Total
  £   £
At 01 April 2024  
Additions 400,000    400,000 
Disposals  
At 31 March 2025 400,000    400,000 

2